Category: Hem/Onc News
Kidney Cancer News
Clinical Advances in Hematology & Oncology October 2016, Volume 14, Issue 10 High Body Mass Index Linked to Improved Survival in Metastatic Renal Carcinoma High […]
Hem/Onc News
Clinical Advances in Hematology & Oncology October 2016, Volume 14, Issue 10 Umbilical Cord Blood Beats HLA-Mismatched Unrelated Donor Cells in Stem Cell Transplant For patients […]
Hem/Onc News
Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Devon Schuyler Users of Dietary Supplements More Likely to Skip Chemotherapy for Breast Cancer […]
Hem/Onc News
Clinical Advances in Hematology & Oncology Volume 14, Issue 5, May 2016 Devon Schuyler Venetoclax Approved for Use in Chronic Lymphocytic Leukemia The US Food and […]
Hem/Onc News
Clinical Advances in Hematology & Oncology April 2016, Volume 14, Issue 4 Devon Schuyler New Formulation of Melphalan Approved for Multiple Myeloma The US Food and […]
Hem/Onc News
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Devon Schuyler Eribulin Approved for Unresectable or Metastatic Liposarcoma The US Food and Drug […]
January News
Ixazomib Approved for Use in Myeloma The US Food and Drug Administration (FDA) approved ixazomib (Ninlaro, Takeda/Millennium) on November 20 for use in patients with multiple […]
Hem/Onc News
Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Devon Schuyler Osimertinib Approved for Use in NSCLC The US Food and Drug Administration […]
November Hem/Onc News
Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Devon Schuyler FDA Approves Pembrolizumab for Metastatic NSCLC The US Food and Drug Administration […]
October News
Rolapitant Approved for Chemotherapy-Induced Nausea and Vomiting The US Food and Drug Administration approved rolapitant (Varubi, Tesaro) on September 2 for chemotherapy-associated nausea and vomiting (CINV). […]
September News
Hem/Onc News By Devon Schuyler Use of Intraperitoneal Chemotherapy in Ovarian Cancer Is Limited Fewer than half of women with stage III ovarian cancer receive intraperitoneal […]
August News
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 ASCO Updates Guidelines on Use of Hematopoietic Colony-Stimulating Factors The prophylactic use of […]
June News
Kathryn Turner, PhD FDA Expands Ramucirumab Indications to Include Metastatic Colorectal Cancer The US Food and Drug Administration (FDA) has approved the use of ramucirumab (Cyramza, […]
Hem/Onc News
Clinical Advances in Hematology & Oncology May 2015, Volume 13, Issue 5 PALOMA-3 Stopped Early Based on Efficacy of Palbociclib A trial of palbociclib […]
FDA News
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 By Kathryn Turner, PhD FDA Approves Panobinostat for Relapsed Multiple Myeloma Panobinostat […]
Hem/Onc News
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 By Kathryn Turner, PhD FDA Approves First US Biosimilar The US Food […]
Hem/Onc News
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 FDA Approves Palbociclib for Breast Cancer Palbociclib (Ibrance, Pfizer) has received accelerated approval […]
Hem/Onc News
Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 FDA Approves Pembrolizumab for Advanced Melanoma The US Food and Drug Administration (FDA) has […]
Hem/Onc News
Clinical Advances in Hematology & Oncology June 2014, Volume 12, Issue 6 By Devon Schuyler FDA Approves Ceritinib in Metastatic ALK-Positive NSCLC The US Food and Drug […]
Hem/Onc News
Clinical Advances in Hematology & Oncology May 2014, Volume 12, Issue 5 FDA Approves Factor IX Agent for Hemophilia B The US Food and Drug Administration […]